$REGN
REGENERON PHARMACEUTICALS, INC.

2021 Q1 Form 10-Q Financial Statement

#000180422021000017 Filed on May 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $2.529B $1.828B
YoY Change 38.32% 33.19%
Cost Of Revenue $308.0M $217.3M
YoY Change 41.74% 26.26%
Gross Profit $2.221B $1.611B
YoY Change 37.85% 34.19%
Gross Profit Margin 87.82% 88.11%
Selling, General & Admin $405.6M $367.3M
YoY Change 10.43% 26.18%
% of Gross Profit 18.26% 22.8%
Research & Development $742.9M $583.9M
YoY Change 27.23% 20.12%
% of Gross Profit 33.45% 36.25%
Depreciation & Amortization $67.40M $56.10M
YoY Change 20.14% 10.0%
% of Gross Profit 3.04% 3.48%
Operating Expenses $1.149B $951.2M
YoY Change 20.74% 22.39%
Operating Profit $1.113B $700.1M
YoY Change 58.93% 45.85%
Interest Expense $14.60M $6.100M
YoY Change 139.34% -20.78%
% of Operating Profit 1.31% 0.87%
Other Income/Expense, Net $140.3M -$31.50M
YoY Change -545.4% -147.66%
Pretax Income $1.253B $668.6M
YoY Change 87.41% 22.43%
Income Tax $137.8M $44.00M
% Of Pretax Income 11.0% 6.58%
Net Earnings $1.115B $624.6M
YoY Change 78.55% 35.46%
Net Earnings / Revenue 44.1% 34.16%
Basic Earnings Per Share $10.58 $5.69
Diluted Earnings Per Share $10.09 $5.43
COMMON SHARES
Basic Shares Outstanding 105.4M shares 109.8M shares
Diluted Shares Outstanding 110.5M shares 115.1M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.504B $4.003B
YoY Change -12.47% 23.86%
Cash & Equivalents $1.438B $2.208B
Short-Term Investments $2.066B $1.795B
Other Short-Term Assets $713.0M $708.0M
YoY Change 0.71% 29.67%
Inventory $2.165B $1.481B
Prepaid Expenses
Receivables $4.173B $2.063B
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.06B $8.644B
YoY Change 16.32% 24.76%
LONG-TERM ASSETS
Property, Plant & Equipment $3.263B $2.945B
YoY Change 10.8% 12.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.584B $3.292B
YoY Change 8.87% 40.68%
Other Assets $145.7M $161.2M
YoY Change -9.62% 11.71%
Total Long-Term Assets $7.717B $7.113B
YoY Change 8.49% 20.03%
TOTAL ASSETS
Total Short-Term Assets $10.06B $8.644B
Total Long-Term Assets $7.717B $7.113B
Total Assets $17.77B $15.76B
YoY Change 12.79% 22.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $543.0M $348.0M
YoY Change 56.03% 45.0%
Accrued Expenses $1.492B $1.143B
YoY Change 30.53% 54.25%
Deferred Revenue $464.9M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $718.0M
YoY Change
Total Short-Term Liabilities $3.218B $2.055B
YoY Change 56.57% 35.98%
LONG-TERM LIABILITIES
Long-Term Debt $1.979B $715.0M
YoY Change 176.77% 0.7%
Other Long-Term Liabilities $571.5M $321.5M
YoY Change 77.76% -14.56%
Total Long-Term Liabilities $2.550B $321.5M
YoY Change 693.28% -14.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.218B $2.055B
Total Long-Term Liabilities $2.550B $321.5M
Total Liabilities $5.795B $3.625B
YoY Change 59.89% 6.29%
SHAREHOLDERS EQUITY
Retained Earnings $12.01B $8.004B
YoY Change 50.02% 39.81%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.935B $1.074B
YoY Change 545.87% 141.74%
Treasury Stock Shares 17.10M shares 5.684M shares
Shareholders Equity $11.98B $12.13B
YoY Change
Total Liabilities & Shareholders Equity $17.77B $15.76B
YoY Change 12.79% 22.58%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $1.115B $624.6M
YoY Change 78.55% 35.46%
Depreciation, Depletion And Amortization $67.40M $56.10M
YoY Change 20.14% 10.0%
Cash From Operating Activities $668.5M $698.0M
YoY Change -4.23% -22.19%
INVESTING ACTIVITIES
Capital Expenditures -$115.3M -$170.1M
YoY Change -32.22% 128.94%
Acquisitions
YoY Change
Other Investing Activities -$943.7M -$273.1M
YoY Change 245.55% -61.09%
Cash From Investing Activities -$1.059B -$443.2M
YoY Change 138.94% -42.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $211.9M -$490.7M
YoY Change -143.18% 275.73%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$366.4M $335.6M
YoY Change -209.18% 179.9%
NET CHANGE
Cash From Operating Activities $668.5M $698.0M
Cash From Investing Activities -$1.059B -$443.2M
Cash From Financing Activities -$366.4M $335.6M
Net Change In Cash -$756.9M $590.4M
YoY Change -228.2% 145.18%
FREE CASH FLOW
Cash From Operating Activities $668.5M $698.0M
Capital Expenditures -$115.3M -$170.1M
Free Cash Flow $783.8M $868.1M
YoY Change -9.71% -10.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000872589
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
0-19034
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
REGENERON PHARMACEUTICALS, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3444607
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
777 Old Saw Mill River Road
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tarrytown
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10591-6707
CY2021Q1 dei City Area Code
CityAreaCode
914
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
847-7000
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock - par value $.001 per share
CY2021Q1 dei Trading Symbol
TradingSymbol
REGN
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1437900000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2193700000 USD
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2065900000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1393300000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4173000000.0 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4114700000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
2164700000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1916600000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
213600000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160800000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
10055100000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
9779100000 USD
CY2021Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3543700000 USD
CY2020Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3135600000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3262600000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3221600000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
765100000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
858900000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
145700000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
168100000 USD
CY2021Q1 us-gaap Assets
Assets
17772200000 USD
CY2020Q4 us-gaap Assets
Assets
17163300000 USD
CY2021Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
542900000 USD
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
475500000 USD
CY2021Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1492200000 USD
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1644200000 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
717800000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
464900000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
577700000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3217800000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2697400000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1978900000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1978500000 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
717200000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
27000000.0 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
57800000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
571500000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
687100000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
5795200000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
6138000000.0 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6887800000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6716200000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12008200000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10893000000.0 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
16200000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29300000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
17104177 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
16431520 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
6935300000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
6613300000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11977000000.0 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11025300000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17772200000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17163300000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2528700000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1828200000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
742900000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
583900000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
405600000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
367300000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
40500000 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
40400000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
1416000000.0 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
1128100000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1112700000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
700100000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
154900000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25400000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
14600000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
6100000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
140300000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-31500000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1253000000.0 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
668600000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
137800000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44000000.0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1115200000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
624600000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.58
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.69
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.09
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.43
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105400000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109800000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110500000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115100000 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1115200000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
624600000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13300000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-28800000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
200000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1400000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1102100000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
594400000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11025300000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
93900000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
66400000 USD
CY2021Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
10000000.0 USD
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
323500000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
135600000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1115200000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13100000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11977000000.0 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11089700000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
817400000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
155100000 USD
CY2020Q1 regn Stock Issued Distributed During Period Value Employee Benefit Plan
StockIssuedDistributedDuringPeriodValueEmployeeBenefitPlan
14600000 USD
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
336000000.0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108000000.0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
624600000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30200000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
12133000000.0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1115200000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
624600000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
67400000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56100000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
130900000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
105800000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
115700000 USD
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-82600000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-10100000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-9900000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
58300000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
169000000.0 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
252800000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
70800000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
50000000.0 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-70100000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-143600000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
73900000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-34700000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-85200000 USD
CY2021Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-446700000 USD
CY2020Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
73400000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
668500000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
698000000.0 USD
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1360000000.0 USD
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
714300000 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
416300000 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
441200000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
115300000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
170100000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1059000000.0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-443200000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
95000000.0 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
811400000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
154500000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
155100000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
306900000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
320700000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-366400000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
335600000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-756900000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
590400000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2207300000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1630300000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1450400000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2220700000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1115200000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
624600000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105400000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109800000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110500000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115100000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.58
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.69
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.09
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.43
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
4584100000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
29300000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6200000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4607200000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3649200000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
40100000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
200000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3689100000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2065900000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1393300000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2541300000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2295800000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
4607200000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3689100000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
1455200000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6200000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
1455200000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
6200000 USD
CY2020Q1 regn Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
0 USD
CY2021Q1 regn Marketable Securities Realized Loss
MarketableSecuritiesRealizedLoss
0 USD
CY2021Q1 regn Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
0 USD
CY2020Q1 regn Marketable Securities Realized Gain
MarketableSecuritiesRealizedGain
0 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
143900000 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-56800000 USD
CY2021Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
40000000.0 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
59200000 USD
CY2021Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1803000000 USD
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1958000000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1437900000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2208200000 USD
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
576200000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
459400000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
971200000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
904600000 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
117900000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
121700000 USD
CY2021Q1 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
499400000 USD
CY2020Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
430900000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
2164700000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1916600000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.110
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.066
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
12500000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1450400000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2220700000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
75600000 USD
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
83600000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
72600000 USD
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
133700000 USD

Files In Submission

Name View Source Status
0001804220-21-000017-index-headers.html Edgar Link pending
0001804220-21-000017-index.html Edgar Link pending
0001804220-21-000017.txt Edgar Link pending
0001804220-21-000017-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image4a.jpg Edgar Link pending
image_01a.jpg Edgar Link pending
image_263a.jpg Edgar Link pending
image_301.jpg Edgar Link pending
image_371.jpg Edgar Link pending
image_381.jpg Edgar Link pending
image_62a.jpg Edgar Link pending
image_811.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
regn-20210331.htm Edgar Link pending
regn-20210331.xsd Edgar Link pending
regn-20210331_cal.xml Edgar Link unprocessable
regn-20210331_def.xml Edgar Link unprocessable
regn-20210331_htm.xml Edgar Link completed
regn-20210331_lab.xml Edgar Link unprocessable
regn-20210331_pre.xml Edgar Link unprocessable
regn-ex_101x3312021x10q.htm Edgar Link pending
regn-ex_311x03312021x10q.htm Edgar Link pending
regn-ex_312x03312021x10q.htm Edgar Link pending
regn-ex_32x03312021x10q.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending